Credentialing UHRF1 as a target for prostate cancer therapy

被引：0
|
作者：
Walker, David [1 ]
Haffner, Michael [1 ]
Deshpande, Neha [1 ]
Wyhs, Nicolas [1 ]
De Marzo, Angelo [1 ]
Yegnasubramanian, Srinivasan [1 ]
Nelson, William [1 ]
机构：
[1] Johns Hopkins Sch Med, Sidney Kimmel Comphrehens Canc Ctr, Baltimore, MD USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-992
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
992
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Epigenetic mechanism and target therapy of UHRF1 protein complex in malignancies
    Xue, Busheng
    Zhao, Jiansong
    Feng, Penghui
    Xing, Jia
    Wu, Hongliang
    Li, Yan
    [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 549 - 559
  • [2] UHRF1: The key regulator of epigenetics and molecular target for cancer therapeutics
    Sidhu, Harsimran
    Capalash, Neena
    [J]. TUMOR BIOLOGY, 2017, 39 (02) : 1 - 11
  • [3] Oncogenic Roles of UHRF1 in Cancer
    Kim, Ahhyun
    Benavente, Claudia A.
    [J]. EPIGENOMES, 2024, 8 (03)
  • [4] Correlation of UHRF1 expression in primary prostate cancer patients with adverse prognosis
    Roggero, Enrico
    Sarti, Manuela
    Pinton, Sandra
    Thalmann, George
    Catapano, Carlo
    Bonapace, Ian Marc
    Carbone, Giuseppina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation
    Peng, Yuchong
    Tang, Rong
    Ding, Liuyang
    Zheng, Rirong
    Liu, Youhong
    Yin, Linglong
    Fu, Yongming
    Deng, Tanggang
    Li, Xiong
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 942
  • [6] UHRF1 Induces Metastasis in Thyroid Cancer
    Kuang, Bo-Hua
    Lin, Guo-He
    Liu, Quentin
    Wang, Bi-Cheng
    [J]. JOURNAL OF ONCOLOGY, 2022, 2022
  • [7] The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression
    F Babbio
    C Pistore
    L Curti
    I Castiglioni
    P Kunderfranco
    L Brino
    P Oudet
    R Seiler
    G N Thalman
    E Roggero
    M Sarti
    S Pinton
    M Mello-Grand
    G Chiorino
    C V Catapano
    G M Carbone
    I M Bonapace
    [J]. Oncogene, 2012, 31 : 4878 - 4887
  • [8] Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy (Review)
    Choudhry, Hani
    Zamzami, Mazin A.
    Omran, Ziad
    Wu, Wei
    Mousli, Marc
    Bronner, Christian
    Alhosin, Mahmoud
    [J]. ONCOLOGY LETTERS, 2018, 15 (01) : 3 - 10
  • [9] Dihydroartemisinin induces cell apoptosis through repression of UHRF1 in prostate cancer cells
    Xia, Tong
    Liu, Sihao
    Xu, Ge
    Zhou, Siji
    Luo, Ziguo
    [J]. ANTI-CANCER DRUGS, 2022, 33 (01) : E113 - E124
  • [10] The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression
    Babbio, F.
    Pistore, C.
    Curti, L.
    Castiglioni, I.
    Kunderfranco, P.
    Brino, L.
    Oudet, P.
    Seiler, R.
    Thalman, G. N.
    Roggero, E.
    Sarti, M.
    Pinton, S.
    Mello-Grand, M.
    Chiorino, G.
    Catapano, C. V.
    Carbone, G. M.
    Bonapace, I. M.
    [J]. ONCOGENE, 2012, 31 (46) : 4878 - 4887
12345